Senores Pharmaceuticals Limited — Others, 15-05-2025: Monitoring Agency Report

Senores Pharmaceuticals Limited has announced a Monitoring Agency Report by CARE Ratings confirming proper utilization of its Rs. 500 crore IPO proceeds. Key uses include Rs. 43.55 crore to repay company borrowings, Rs. 3.91 crore for subsidiary loan repayment, Rs. 20.17 crore for working capital, and Rs. 35.72 crore for inorganic growth through an ANDA acquisition. Remaining Rs. 343.25 crore is invested in fixed deposits earning 5.5-7.25% interest. Deployment delays were resolved with extensions. The fund use supports the company’s planned business and growth strategies.